Gmeiner WH, Boyacioglu O, Stuart CH, Jennings-Gee J, Balaji KC. The cytotoxic and pro-apoptotic activities of the novel fluoropyrimidine F10 towards prostate cancer cells are enhanced by Zn(2+) -chelation and inhibiting the serine protease Omi/HtrA2. Prostate. 2015;75(4):360-369.
Fang X, Gyabaah K, Nickkholgh B, Cline JM, Balaji KC. Novel in vivo model for combinatorial fluorescence labeling in mouse prostate. Prostate. 2015;75(9):988-1000.
Balaji KC. Long-term survival rates after resection for locally advanced kidney cancer: Memorial Sloan Kettering Cancer Center 1989 to 2012 experience [editorial comment]. J Urol. 2015;193(6):1916-1917.
Balaji KC. Autophagy: friend or foe for progression and treatment of urothelial carcinoma [editorial]. J Urol. 2014;191(6):1644-1645.
Wicks EE, Fang XL, Balaji KC. Prorainbow: a novel in vivo prostate mouse model to track the origin of prostate cancer [abstract]. Tissue Eng Part A. 2014;20(Suppl 1):S139-S140.
Nickkholgh B, Fang XL, Gyabaah K, Balaji KC. Biological basis of aggressive phenotype in African-American prostate cancer cell line [abstract]. Cancer Res. 2014;74(19 Suppl):A4000.
Krane LS, Richards KA, Kader AK, Davis R, Balaji KC, Hemal AK. Preoperative neutrophil/lymphocyte ratio predicts overall survival and extravesical disease in patients undergoing radical cystectomy. J Endourol. 2013;27(8):1046-1050.
Fang X, Sittadjody S, Gyabaah K, Opara EC, Balaji KC. Novel 3D co-culture model for epithelial-stromal cells interaction in prostate cancer. PLoS One. 2013;8(9):e75187.
Fang XL, Sivanandane S, Gyabaah K Balaji KC. Novel 3D co-cultural model for epithelial-stromal cells interaction in prostate cancer [abstract]. Cancer Res. 2013;73(8 Suppl 1):A4078.
Balaji KC. Metastatic potential of a renal mass according to original tumour size at presentation [editorial comment]. BJU Int. 2012;109(2):194.
Du C, Zhang C, Li Z, Biswas MHU, Balaji KC. Beta-catenin phosphorylated at threonine 120 antagonizes generation of active beta-catenin by spatial localization in trans-Golgi network. PLoS ONE. 2012;7(4):e33830.
For a listing of recent publications, refer to PubMed, a service provided by the National Library of Medicine.
For a list of earlier publications, visit the Carpenter Library Publication Search.
Minimally Invasive Surgery, Urologic Oncology, Robotic Urologic Surgery, Laparoscopic Surgery
The overall Patient Rating score is the average of responses to the nine questions listed below. The questions are from the Press Ganey Patient Satisfaction Survey. Responses are measured on a 1 to 5 scale, where 1 represents "very poor" and 5 represents "very good."
Comments are taken from the Care Provider section of the Press Ganey Patient Satisfaction Survey. Comments are posted exactly as they are written. Comments are added weekly. To protect patient privacy and confidentiality, patient names are not included.
I would recommend Dr. Balaji for sure.
Good news is always easy.......
Total trust in the Doctor, Have Highly recommended him to other people that I know with the same issues I have.
Excellent doctor who is willing to take extra time with his patients if needed. I have total trust in his treatment of my problem.
Good doctor & staff.
*Dr. Balaji is extremely professional, explains your current situation & issues in a caring & upbeat manner.
I have utmost confidence in Dr. Balaji.
Excellent physician, very high level of knowledge, very current on research, skilled in helping me make decisions
He is down to earth, approachable, and inspires confidence.
Have lots of faith in Dr. Balaji.
An excellent Dr
Dr. Balaji is very good, competent, knowledgeable & forthcoming with information.
they made me feel important
Dr. Balaji is a very caring, competent, and skillful physician who makes a special effort to communicate with patients and family. We drove from the coast past Duke and UNC to see him and have been very pleased.
Simply the best!